Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Kapoor R, Furby J, Hayton T, Smith KJ, Altmann DR, Brenner R, Chataway J, Hughes R A, Miller DH Lancet Neurol. 2010 Jul; 9(7):681-8. Epub 2010 Jun 08. PMID: 20621711. Abstract CommentRecommendBookmarkWatch